psychedelics
R&D/ Views & Analysis/ Views and analysis
Can psychedelics provide breakthrough in mental health?
Ben Hargreaves
DMT, LSD, psilocybin, psychedelics, WHO
0 Comment
Otsuka dips its toe in psychedelic waters, backing Mindset Pharma
Phil Taylor
investment, Mindset Pharma, Otsuka, partnering, psychedelics
0 Comment
Mydecine, Maya team up on digital tools for psychedelic drugs
Phil Taylor
digital, digital health, Maya Health, Mydecine, psychedelics
0 Comment
Compass points to positive psilocybin trial, but shares fall
Phil Taylor
Compass Pathways, depression, psychedelics, Psychiatry
0 Comment
Psychedelics startup Beckley attracts Janssen neuroscience VP
Phil Taylor
appointment, Beckley Psytech, Janssen, psychedelics, senior management
0 Comment
First subject dosed in psilocybin trial for rare headache disorder
Phil Taylor
Beckley Psytech, central nervous system, neurology, psychedelics, Psychiatry
0 Comment
Beckley Psytech raises $80m for psychedelic meds development
Phil Taylor
Beckley Psytech, central nervous system, neurology, psychedelics, Psychiatry
0 Comment